Woburn, Massachusetts, USA
August 5, 2020

Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that it established 50 acres of spring Camelina under contract with a grower in Montana in the second quarter of 2020. This is a business development activity necessary to gain experience in establishing the value chain for producing Camelina sativa seed at large scale as a source of new crop products. The objective of this activity was to gain experience in seed bulk-up, grower contracts, logistics and handling of harvested seed, including toll crushing, and to produce quantities of oil and protein meal for customer sampling. The crop has reached maturity and is currently drying down with harvesting expected in the weeks ahead.

Yield10 Bioscience 50 acres of Camelina planted in Montana, July 2020.

“The successful establishment of spring Camelina at the 50 acre scale is a significant milestone for Yield10 as we continue to advance our business plan for developing Camelina seed products,” said Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield10 Bioscience. “As we develop improved Camelina varieties and deploy new performance and composition traits, our goal is to use a capital efficient approach to the commercial launch of our Camelina products. We envision opportunities for collaborations and other commercial arrangements to drive the generation of value from the sale of Camelina oil and meal in the near term followed by the specialty products currently in development.”

Website: http://www.yield10bio.com

Published: August 5, 2020